Page last updated: 2024-10-19

phenethylamine and Peripheral Nervous System Diseases

phenethylamine has been researched along with Peripheral Nervous System Diseases in 1 studies

phenethylamine: RN given refers to parent cpd; structure in Merck Index, 9th ed, #7016
2-phenylethylamine : A phenylethylamine having the phenyl substituent at the 2-position.

Peripheral Nervous System Diseases: Diseases of the peripheral nerves external to the brain and spinal cord, which includes diseases of the nerve roots, ganglia, plexi, autonomic nerves, sensory nerves, and motor nerves.

Research Excerpts

ExcerptRelevanceReference
"Concentrations of PEA in CSF in Parkinson's disease were significantly lower (mean 205 (SD 131) pg/ml) than in patients with peripheral neuropathy (433 (SD 254) pg/ml) and controls (387 (SD 194) pg/ml)."1.30Decreased beta-phenylethylamine in CSF in Parkinson's disease. ( Matsuishi, T; Shoji, H; Yamada, S; Zhou, G, 1997)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zhou, G1
Shoji, H1
Yamada, S1
Matsuishi, T1

Other Studies

1 other study available for phenethylamine and Peripheral Nervous System Diseases

ArticleYear
Decreased beta-phenylethylamine in CSF in Parkinson's disease.
    Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 63, Issue:6

    Topics: Aged; Chromatography, Gas; Female; Homovanillic Acid; Humans; Levodopa; Male; Mass Spectrometry; Mid

1997